A peanut patch showed promising results in a late-phase clinical trial in toddlers with peanut allergies, according to a new study.Researchers from the French biopharmaceutical firm DBV Technologies and institutions around the world conducted randomized double-blind trial of the Viaskin Peanut patch in children ages 1 through 3 years old who had been diagnosed with a peanut allergy, they reported Wednesday in The New England Journal of Medicine.
#years #researchers #application #participants #introduction #institutions #limitations #news-release #infectious-diseases #immune-systems
[
add
]
[
|
|
...
]